Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris - 21/08/11
James Leyden, MD, KGL Skin Study Center, Broomall, PA, United States; Diane Thiboutot, MD, Pennsylvania State University College of Medicine, Hershey, PA, United States; Alan Shalita, MD, State University of New York Downstate Medical Center, Brooklyn, NY, United States; Guy Webster, MD, PhD, Jefferson Medical College, Philadelphia, PA, United States
Le texte complet de cet article est disponible en PDF. P121 Dr. Leyden is a consultant for Allergan, Inc., Medicis, Galderma Laboratories, Inc., Stiefel Laboratories, Inc., Dermik Laboratories, Inc., CollaGenex Pharmaceuticals, Inc., and Connetics Corporation. Dr Thiboutot is a consultant and investigator for Allergan, Inc. Dr Shalita is a consultant and investigator for Allergan, Inc. and Medicis. Dr Webster is a consultant, speaker, and investigator for Allergan, Inc. and Medicis. Supported by Allergan, Inc. |
Vol 52 - N° 3S
P. P15 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?